CLINICAL TRIALS PROFILE FOR REGRANEX
✉ Email this page to a colleague
All Clinical Trials for REGRANEX
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00034788 ↗ | A Study on the Efficacy and Safety of Long-Term Treatment and Re-Treatment of Lower Extremity Diabetic Ulcers With REGRANEX | Terminated | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Phase 3 | 2000-12-01 | The purpose of this study is to evaluate the efficacy and safety of REGRANEX® Gel compared with placebo when applied for up to 52 consecutive weeks to recurring or non-healing ulcers of the ankle or foot related to diabetes. |
| NCT00389636 ↗ | TheraGauze™ Alone and Regranex®Gel 0.01% Plus TheraGauze™ in the Treatment of Wagner Stage I Diabetic Foot Ulcers | Unknown status | Solsys Medical LLC | N/A | 2006-09-01 | Patients will be randomized to receive TheraGauze alone or with Regranex to treat diabetic foot ulcer condition. The purpose of the study is provide the sponsor with pilot information regarding the ability of TheraGauze to promote wound healing on its own and to examine synergy with Regranex in the treatment of diabetic foot ulcers. |
| NCT00389636 ↗ | TheraGauze™ Alone and Regranex®Gel 0.01% Plus TheraGauze™ in the Treatment of Wagner Stage I Diabetic Foot Ulcers | Unknown status | Soluble Systems, LLC | N/A | 2006-09-01 | Patients will be randomized to receive TheraGauze alone or with Regranex to treat diabetic foot ulcer condition. The purpose of the study is provide the sponsor with pilot information regarding the ability of TheraGauze to promote wound healing on its own and to examine synergy with Regranex in the treatment of diabetic foot ulcers. |
| NCT00446472 ↗ | Evaluation of Windowed Casts With and Without Regranex® Gel for Healing Diabetic Neuropathic Ulcers | Unknown status | Heritage Medical Research Institute | N/A | 2007-04-01 | The objective of this study is to compare the effectiveness and safety of windowed casts with Regranex® (topical becaplermin gel) versus placebo (inactive medication) for treatment of diabetic ulcers on the legs and feet. |
| NCT00446472 ↗ | Evaluation of Windowed Casts With and Without Regranex® Gel for Healing Diabetic Neuropathic Ulcers | Unknown status | Southern California Institute for Research and Education | N/A | 2007-04-01 | The objective of this study is to compare the effectiveness and safety of windowed casts with Regranex® (topical becaplermin gel) versus placebo (inactive medication) for treatment of diabetic ulcers on the legs and feet. |
| NCT00518102 ↗ | The Risk of Cancer in Users of Regranex (Becaplermin) and Matched Comparators (Nonusers of Regranex [Becaplermin]) | Completed | Ethicon, Inc. | 2003-01-01 | The purpose of this study is to compare the risk of cancers in patients who have used REGRANEX (becaplermin) to that of patients with similar characteristics and health issues who have not used REGRANEX (becaplermin). REGRANEX (becaplermin) is topical medication used to treat non-healing neuropathic foot ulcers in patients with diabetes. | |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for REGRANEX
Condition Name
Clinical Trial Locations for REGRANEX
Trials by Country
Clinical Trial Progress for REGRANEX
Clinical Trial Phase
Clinical Trial Sponsors for REGRANEX
Sponsor Name
